Glioblastoma multiforme (GBM), WHO classification name “glioblastoma”, is the most common and most aggressive malignant primary brain tumor in humans, involving glial cells and accounting for 52% of all functional tissue brain tumor cases and 20% of all intracranial tumors. GBM is rare, with incidence of 2–3 cases per 100,000 in Europe and North America. It presents two variants: giant cell glioblastoma and gliosarcoma. Treatment can involve chemotherapy, radiation and surgery.
allergen Alzheimer's disease American Heart Association Arachis hypogaea breast cancer business enterprise cancer cardiovascular system disease chronic condition construction dementia disability disease employment EMR food allergy Gastrointestinal tract gut flora Health and Safety Executive Health IT health professional hepatocellular carcinoma Hospital infection inflammation injury insurance liver marijuana mental disorder mental health neoplasm occupational safety and health officer opioid pain patient research safety Surgery symptom type I hypersensitivity United States of America woman Workers' compensation